Molina Cateriano, C., Toyoda, K., Bereczki, D., Kasner, S. E., Lutsep, H. L., & Sharma, M. (2022). Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention.

Molina Cateriano, Carlos, Kazunori Toyoda, Daniel Bereczki, Scott E. Kasner, Helmi L. Lutsep, e Mukul Sharma. Rationale and Design of the AXIOMATIC-SSP Phase II Trial: Antithrombotic Treatment With Factor XIa Inhibition to Optimize Management of Acute Thromboembolic Events for Secondary Stroke Prevention. 2022.

Molina Cateriano, Carlos, et al. Rationale and Design of the AXIOMATIC-SSP Phase II Trial: Antithrombotic Treatment With Factor XIa Inhibition to Optimize Management of Acute Thromboembolic Events for Secondary Stroke Prevention. 2022.